Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Annals of Hematology|March 24, 1999
Spontaneous remission in myelodysplastic syndromeJ G Dervenoulas, P Tsirigotis, G Bollas, et al.Critical Reviews in Oncology/Hematology|February 17, 2007
Allogeneic hematopoietic stem cell transplantation in the elderlyMichael Y Shapira, P Tsirigotis, I B Resnick, et al.Leukemia Research|December 21, 2004
A novel p27 gene mutation in a case of unclassified myeloproliferative disorderV Pappa, S Papageorgiou, E Papageorgiou, et al.European Journal of Haematology|September 21, 2000
Splenectomy in patients with malignant non-Hodgkin's lymphomaN Xiros, T Economopoulos, C Christodoulidis, et al.Oncology|November 27, 2001
T-cell-rich B-cell lymphoma. Analysis of clinical features, response to treatment, survival and comparison with diffuse large B-cell lymphomaP Tsirigotis, T Economopoulos, D Rontogianni, et al.Bone Marrow Transplantation|December 13, 2016
Low-dose alemtuzumab for GvHD prevention followed by prophylactic donor lymphocyte infusions in high-risk leukemiaP Tsirigotis, M Liga, K Gkirkas, et al.Bone Marrow Transplantation|October 14, 2008
Alefacept treatment for refractory chronic extensive GVHDM Y Shapira, A Abdul-Hai, I B Resnick, et al.Annals of Hematology|March 31, 2000
Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 casesJ Dervenoulas, P Tsirigotis, G Bollas, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 21, 2012
Radiotherapy for Hodgkin's lymphoma: too hard to die?A G Zygogianni, G Kyrgias, A Psyrri, et al.Bone Marrow Transplantation|December 1, 2009
The number of infused CD34+ cells does not influence the incidence of GVHD or the outcome of allogeneic PBSC transplantation, using reduced-intensity conditioning and antithymocyte globulinP Tsirigotis, M Y Shapira, R Or, et al.Pageof 3